Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atul Bioscience
Atul, Gujarat, Indiaatulbio.co.in ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Atul Bioscience manufactures and markets about twenty APIs and intermediates for global pharmaceutical customers. Its portfolio includes established commercial products such as acyclovir, desvenlafaxine, fluconazole, losartan potassium, valacyclovir, venlafaxine. The company’s facilities are US FDA-inspected and certified. No clinical trial results are reported as it does not develop proprietary drugs.
In FY2023–24 the company reported sales of ₹13,090 lakhs ($15.7M) with a profit before tax of ₹288 lakhs ($345K).
The Ambernath facility received an Establishment Inspection Report from the US FDA in May 2024 with zero observations.
The business focus has shifted to more strategic areas within APIs/intermediates over the past year.
- Therapeutic areas
- PulmonologyOncologyEndocrinologyPsychiatryCardiovascularInfectious Diseases
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
None specifically disclosed; serves global pharma companies as clients.
Beyond the preview
Go deeper on Atul Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atul Bioscience.